No connection

Search Results

BEAM vs BKD

BEAM
Beam Therapeutics Inc.
BEARISH
Price
$31.56
Market Cap
$3.2B
Sector
Healthcare
AI Confidence
65%
BKD
Brookdale Senior Living Inc.
BEARISH
Price
$12.95
Market Cap
$3.08B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
BEAM
--
BKD
--
Forward P/E
BEAM
-6.85
BKD
-23.33
P/B Ratio
BEAM
3.22
BKD
-462.5
P/S Ratio
BEAM
57.5
BKD
1.0
EV/EBITDA
BEAM
-4.93
BKD
18.07

Profitability

Gross Margin
BEAM
0.0%
BKD
27.57%
Operating Margin
BEAM
-1307.6%
BKD
2.36%
Profit Margin
BEAM
0.0%
BKD
-9.95%
ROE
BEAM
-47.19%
BKD
-212.27%
ROA
BEAM
-23.48%
BKD
0.92%

Growth

Revenue Growth
BEAM
-32.0%
BKD
4.2%
Earnings Growth
BEAM
--
BKD
--

Financial Health

Debt/Equity
BEAM
0.16
BKD
--
Current Ratio
BEAM
6.02
BKD
0.84
Quick Ratio
BEAM
5.89
BKD
0.5

Dividends

Dividend Yield
BEAM
--
BKD
--
Payout Ratio
BEAM
0.0%
BKD
0.0%

AI Verdict

BEAM BEARISH

The Advanced Deterministic Scorecard reveals a critically weak financial health profile with a Piotroski F-Score of just 1/9, indicating severe operational and profitability concerns. Despite a strong analyst recommendation of 'strong_buy' and a target price implying 44% upside, the company exhibits negative gross and operating margins, deteriorating revenue growth, and deeply negative returns on equity and assets. Insider selling activity totaling $3.19M over the past six months contradicts the bullish analyst sentiment, while valuation multiples like a Price/Sales ratio of 57.50 are extremely stretched relative to fundamentals. Although the current ratio is strong at 6.02, suggesting near-term liquidity safety, the lack of Altman Z-Score and persistent unprofitability elevate long-term sustainability risks.

Strengths
Exceptionally strong liquidity position with a current ratio of 6.02 and quick ratio of 5.89, providing runway for R&D and operations
Low debt burden with a Debt/Equity ratio of 0.16, well below sector average of 2.71, reducing financial risk
Analyst consensus is strongly bullish with a 'strong_buy' rating from 15 analysts and a mean target price of $45.47
Risks
Critically low Piotroski F-Score of 1/9 signals severe financial distress and poor fundamental strength
Operating margin of -1307.60% and gross margin of 0.00% indicate no viable path to profitability in the near term
Revenue growth is sharply negative at -32.00% YoY, reversing prior growth trends and signaling weakening commercial momentum
BKD BEARISH

The Advanced Deterministic Scorecard reveals a deeply concerning financial profile for Brookdale Senior Living (BKD), with a Piotroski F-Score of just 2/9 indicating severe weakness in fundamental health. Despite strong recent price performance (+163.2% over 1Y), the company is unprofitable (ROE: -212.27%, Profit Margin: -9.95%), carries significant liquidity risk (Current Ratio: 0.84), and has consistently missed earnings estimates—0 out of the last 4 quarters beaten, with an average surprise of -101.87%. Valuation metrics are distorted (Price/Book: -462.50, Forward P/E: -23.33) due to negative equity and earnings, while the lack of an Altman Z-Score suggests potential distress risk. Analysts rate it a 'strong_buy' but with only 4 analysts and no meaningful insider activity, the bullish sentiment lacks conviction.

Strengths
Revenue growth of 4.20% YoY shows modest top-line resilience in a challenging senior care environment
Gross margin of 27.57% indicates some operational efficiency at the core service level
Price/Sales ratio of 1.00 is reasonable relative to unprofitable peers in the healthcare sector
Risks
Piotroski F-Score of 2/9 signals extreme financial distress and poor earnings quality
Negative book value and ROE of -212.27% indicate eroding shareholder equity and likely balance sheet insolvency
Current Ratio of 0.84 and Quick Ratio of 0.50 reveal acute liquidity risk and inability to meet short-term obligations

Compare Another Pair

BEAM vs BKD: Head-to-Head Comparison

This page compares Beam Therapeutics Inc. (BEAM) and Brookdale Senior Living Inc. (BKD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile